SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-224165
Filing Date
2008-11-04
Accepted
2008-11-04 14:29:05
Documents
7
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 569609
2 AMENDMENT NO. 1 TO LICENSE AGREEMENT - EPICEPT CORPORATION dex1051.htm EX-10.51 25074
3 DEVELOPMENT AND LICENSE AGREEMENT - ALPHARMA IRELAND LIMITED dex1052.htm EX-10.52 363483
4 RULE 13A-14(A) SECTION 302 CERTIFICATION OF JAMES E. BROWN dex311.htm EX-31.1 8916
5 RULE 13A-14(A) SECTION 302 CERTIFICATION OF MATTHEW J. HOGAN dex312.htm EX-31.2 8926
6 CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350 OF JAMES E. BROWN dex321.htm EX-32.1 2793
7 CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350 OF MATTHEW J. HOGAN dex322.htm EX-32.2 2803
  Complete submission text file 0001193125-08-224165.txt   982967
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 081160378
SIC: 2834 Pharmaceutical Preparations